Found: 14
Select item for more details and to access through your institution.
CART-Cell Therapy: Recent Advances and New Evidence in Multiple Myeloma.
- Published in:
- Cancers, 2021, v. 13, n. 11, p. 2639, doi. 10.3390/cancers13112639
- By:
- Publication type:
- Article
Autologous Stem Cell Transplantation in Patients With Multiple Myeloma: An Activity-based Costing Analysis, Comparing a Total Inpatient Model Versus an Early Discharge Model.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Tolerability and efficacy of busulfan and fludarabine as allogeneic pretransplant conditioning therapy in acute myeloid leukemia: comparison with busulfan and cyclophosphamide regimen.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Long-term results in multiple myeloma after high-dose melphalan and autologous transplantation according to response categories in the era of old drugs.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Mobilization of hematopoietic progenitor stem cells in allogeneic setting with lenograstim by subcutaneous injection, in daily or twice-daily dosing: a single-center prospective study with historical control.
- Published in:
- Transfusion, 2015, v. 55, n. 8, p. 2032, doi. 10.1111/trf.13117
- By:
- Publication type:
- Article
Identification of hematopoietic progenitor cell donor characteristics predicting successful mobilization: results of an Italian multicenter study.
- Published in:
- Transfusion, 2014, v. 54, n. 8, p. 2028, doi. 10.1111/trf.12612
- By:
- Publication type:
- Article
The power of telemedicine to improve CAR-T cell therapy programs: lessons learned from COVID-19 pandemic.
- Published in:
- Supportive Care in Cancer, 2023, v. 31, n. 6, p. 1, doi. 10.1007/s00520-023-07811-6
- By:
- Publication type:
- Article
Netupitant/palonosetron without dexamethasone for preventing nausea and vomiting in patients with multiple myeloma receiving high-dose melphalan for autologous stem cell transplantation: a single-center experience.
- Published in:
- Supportive Care in Cancer, 2022, v. 30, n. 1, p. 585, doi. 10.1007/s00520-021-06472-7
- By:
- Publication type:
- Article
Managing leukapheresis in adult and pediatric patients eligible for chimeric antigen receptor T-cell therapy: suggestions from an italian expert Panel.
- Published in:
- Blood Transfusion (17232007), 2023, v. 21, n. 6, p. 514, doi. 10.2450/BloodTransfus.471
- By:
- Publication type:
- Article
Improved outcome of patients with relapsed/refractory Hodgkin lymphoma with a new fotemustine-based high-dose chemotherapy regimen.
- Published in:
- British Journal of Haematology, 2016, v. 172, n. 1, p. 111, doi. 10.1111/bjh.13803
- By:
- Publication type:
- Article
Correction to: Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after high‑dose melphalan and autologous stem cell transplantation.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 2297, doi. 10.1007/s00277-023-05323-1
- By:
- Publication type:
- Article
Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after high-dose melphalan and autologous stem cell transplantation.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 7, p. 1915, doi. 10.1007/s00277-023-05228-z
- By:
- Publication type:
- Article
A comparative effectiveness study of lipegfilgrastim in multiple myeloma patients after high dose melphalan and autologous stem cell transplant.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Effectiveness of CAR-T treatment toward the potential risk of second malignancies.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1384002
- By:
- Publication type:
- Article